The Patent Finder

Novoneuron, Inc.

Also on record
Records under this name other than patents Novoneuron, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Novoneuron, Inc.

PatentTitleStatus Expires Confidence
US 7,754,710Noribogaine in the treatment of pain and drug addiction
Formerly held
Term ended
Term ended Mar 21, 2019 · From the USPTO record
Term endedTerm ended Mar 21, 2019From the USPTO record
US 8,178,524Noribogaine in the treatment of pain and drug addiction
Formerly held
Term ended
Ended no later than Sep 3, 2018 · From the USPTO record
Term endedEnded no later than Sep 3, 2018From the USPTO record
US 7,220,737Noribogaine in the treatment of pain and drug addiction
Formerly held
Lapsed on the fee record
Ended May 22, 2015 · From the USPTO record
Lapsed on the fee recordEnded May 22, 2015From the USPTO record
US 6,348,456Method of treating chemical dependency in mammals and a composition therefor
Formerly held
Term ended
Term ended Feb 1, 2015 · From the USPTO record
Term endedTerm ended Feb 1, 2015From the USPTO record
US 5,591,738Method of treating chemical dependency using .beta.-carboline alkaloids, derivatives and salts thereof
Term ended
Term ended no later than Jan 7, 2017 · Low confidence
Term endedTerm ended no later than Jan 7, 2017Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited